Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1995 Nov;72(5):1180–1188. doi: 10.1038/bjc.1995.483

Allelotype of squamous cell carcinoma of the head and neck: fractional allele loss correlates with survival.

J K Field 1, H Kiaris 1, J M Risk 1, C Tsiriyotis 1, R Adamson 1, V Zoumpourlis 1, H Rowley 1, K Taylor 1, J Whittaker 1, P Howard 1, et al.
PMCID: PMC2033926  PMID: 7577465

Abstract

Allelic imbalance or loss of heterozygosity (LOH) studies have been used extensively to identify regions on chromosomes that may contain putative tumour-suppressor genes. We have undertaken an extensive allelotype of 80 specimens of squamous cell carcinoma of the head and neck (SCCHN) using 145 polymorphic microsatellite markers on 39 chromosome arms. Allelic imbalances were found most frequently on chromosome arms 3p, 9p, 17p and 18q with over 45% LOH and imbalances on 1p, 1q, 2p, 5q, 6p, 6q, 8p, 8q, 9q, 11q, 13q, 17q and 19q were found in more than 20% of SCCHN. These LOH data were analysed against a range of clinicopathological parameters which included previously untreated and previously treated tumours; correlations were found between LOH on 9q and nodes at pathology (P = 0.02) and between histopathological grade and LOH on 12q (P = 0.02) and 13q (P = 0.01). In the group of previously untreated tumours, a correlation was found between site of tumour and LOH on 3p (P = 0.019), and 8p (P = 0.029), while TNM staging correlated with LOH on 3p (P = 0.019) and 17p (P = 0.016). Fractional allele loss (FAL) was calculated for 52 tumours with LOH data on nine or more chromosomal arms and found to have a median value of 0.22 (range 0.0-0.80). Correlations were found between FAL > median value and nodes at pathology (P = 0.01) and tumour grade (P = 0.06), demonstrating that advanced tumours with lymph node metastasis often had LOH at multiple sites. FAL > median value was found to correlate with a poor survival (P < 0.03) and, furthermore, FAL > median value correlated with poor survival in the previously untreated patients (P < 0.019). These results indicate that assessment of the accumulation of genetic damage, as provided by allelotype data, provides a useful molecular indicator of the tumour behaviour and clinical outcome.

Full text

PDF
1180

Images in this article

1182Figure 1
on p.1182

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adamson R., Jones A. S., Field J. K. Loss of heterozygosity studies on chromosome 17 in head and neck cancer using microsatellite markers. Oncogene. 1994 Jul;9(7):2077–2082. [PubMed] [Google Scholar]
  2. Ah-See K. W., Cooke T. G., Pickford I. R., Soutar D., Balmain A. An allelotype of squamous carcinoma of the head and neck using microsatellite markers. Cancer Res. 1994 Apr 1;54(7):1617–1621. [PubMed] [Google Scholar]
  3. Aoki T., Mori T., Du X., Nisihira T., Matsubara T., Nakamura Y. Allelotype study of esophageal carcinoma. Genes Chromosomes Cancer. 1994 Jul;10(3):177–182. doi: 10.1002/gcc.2870100305. [DOI] [PubMed] [Google Scholar]
  4. Brennan J. A., Boyle J. O., Koch W. M., Goodman S. N., Hruban R. H., Eby Y. J., Couch M. J., Forastiere A. A., Sidransky D. Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. N Engl J Med. 1995 Mar 16;332(11):712–717. doi: 10.1056/NEJM199503163321104. [DOI] [PubMed] [Google Scholar]
  5. Cunningham C., Dunlop M. G., Wyllie A. H., Bird C. C. Deletion mapping in colorectal cancer of a putative tumour suppressor gene in 8p22-p21.3. Oncogene. 1993 May;8(5):1391–1396. [PubMed] [Google Scholar]
  6. Field J. K., Kiaris H., Howard P., Vaughan E. D., Spandidos D. A., Jones A. S. Microsatellite instability in squamous cell carcinoma of the head and neck. Br J Cancer. 1995 May;71(5):1065–1069. doi: 10.1038/bjc.1995.205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Field J. K. Oncogenes and tumour-suppressor genes in squamous cell carcinoma of the head and neck. Eur J Cancer B Oral Oncol. 1992 Jul;28B(1):67–76. doi: 10.1016/0964-1955(92)90016-t. [DOI] [PubMed] [Google Scholar]
  8. Field J. K., Spandidos D. A., Malliri A., Gosney J. R., Yiagnisis M., Stell P. M. Elevated P53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck. Br J Cancer. 1991 Sep;64(3):573–577. doi: 10.1038/bjc.1991.352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Field J. K., Spandidos D. A., Stell P. M., Vaughan E. D., Evan G. I., Moore J. P. Elevated expression of the c-myc oncoprotein correlates with poor prognosis in head and neck squamous cell carcinoma. Oncogene. 1989 Dec;4(12):1463–1468. [PubMed] [Google Scholar]
  10. Fujimori M., Tokino T., Hino O., Kitagawa T., Imamura T., Okamoto E., Mitsunobu M., Ishikawa T., Nakagama H., Harada H. Allelotype study of primary hepatocellular carcinoma. Cancer Res. 1991 Jan 1;51(1):89–93. [PubMed] [Google Scholar]
  11. Fujino T., Risinger J. I., Collins N. K., Liu F. S., Nishii H., Takahashi H., Westphal E. M., Barrett J. C., Sasaki H., Kohler M. F. Allelotype of endometrial carcinoma. Cancer Res. 1994 Aug 15;54(16):4294–4298. [PubMed] [Google Scholar]
  12. Fujiwara Y., Emi M., Ohata H., Kato Y., Nakajima T., Mori T., Nakamura Y. Evidence for the presence of two tumor suppressor genes on chromosome 8p for colorectal carcinoma. Cancer Res. 1993 Mar 1;53(5):1172–1174. [PubMed] [Google Scholar]
  13. Jin Y. S., Heim S., Mandahl N., Biörklund A., Wennerberg J., Mitelman F. Unrelated clonal chromosomal aberrations in carcinomas of the oral cavity. Genes Chromosomes Cancer. 1990 Jan;1(3):209–215. doi: 10.1002/gcc.2870010304. [DOI] [PubMed] [Google Scholar]
  14. Jin Y., Mertens F., Mandahl N., Heim S., Olegård C., Wennerberg J., Biörklund A., Mitelman F. Chromosome abnormalities in eighty-three head and neck squamous cell carcinomas: influence of culture conditions on karyotypic pattern. Cancer Res. 1993 May 1;53(9):2140–2146. [PubMed] [Google Scholar]
  15. Knowles M. A., Elder P. A., Williamson M., Cairns J. P., Shaw M. E., Law M. G. Allelotype of human bladder cancer. Cancer Res. 1994 Jan 15;54(2):531–538. [PubMed] [Google Scholar]
  16. Lasko D., Cavenee W., Nordenskjöld M. Loss of constitutional heterozygosity in human cancer. Annu Rev Genet. 1991;25:281–314. doi: 10.1146/annurev.ge.25.120191.001433. [DOI] [PubMed] [Google Scholar]
  17. Latif F., Fivash M., Glenn G., Tory K., Orcutt M. L., Hampsch K., Delisio J., Lerman M., Cowan J., Beckett M. Chromosome 3p deletions in head and neck carcinomas: statistical ascertainment of allelic loss. Cancer Res. 1992 Mar 15;52(6):1451–1456. [PubMed] [Google Scholar]
  18. Li X., Lee N. K., Ye Y. W., Waber P. G., Schweitzer C., Cheng Q. C., Nisen P. D. Allelic loss at chromosomes 3p, 8p, 13q, and 17p associated with poor prognosis in head and neck cancer. J Natl Cancer Inst. 1994 Oct 19;86(20):1524–1529. doi: 10.1093/jnci/86.20.1524. [DOI] [PubMed] [Google Scholar]
  19. Loughran O., Edington K. G., Berry I. J., Clark L. J., Parkinson E. K. Loss of heterozygosity of chromosome 9p21 is associated with the immortal phenotype of neoplastic human head and neck keratinocytes. Cancer Res. 1994 Oct 1;54(19):5045–5049. [PubMed] [Google Scholar]
  20. Maestro R., Gasparotto D., Vukosavljevic T., Barzan L., Sulfaro S., Boiocchi M. Three discrete regions of deletion at 3p in head and neck cancers. Cancer Res. 1993 Dec 1;53(23):5775–5779. [PubMed] [Google Scholar]
  21. Merlo A., Gabrielson E., Askin F., Sidransky D. Frequent loss of chromosome 9 in human primary non-small cell lung cancer. Cancer Res. 1994 Feb 1;54(3):640–642. [PubMed] [Google Scholar]
  22. Morita R., Ishikawa J., Tsutsumi M., Hikiji K., Tsukada Y., Kamidono S., Maeda S., Nakamura Y. Allelotype of renal cell carcinoma. Cancer Res. 1991 Feb 1;51(3):820–823. [PubMed] [Google Scholar]
  23. Nawroz H., van der Riet P., Hruban R. H., Koch W., Ruppert J. M., Sidransky D. Allelotype of head and neck squamous cell carcinoma. Cancer Res. 1994 Mar 1;54(5):1152–1155. [PubMed] [Google Scholar]
  24. Nishisho I., Nakamura Y., Miyoshi Y., Miki Y., Ando H., Horii A., Koyama K., Utsunomiya J., Baba S., Hedge P. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science. 1991 Aug 9;253(5020):665–669. doi: 10.1126/science.1651563. [DOI] [PubMed] [Google Scholar]
  25. Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer. 1976 Dec;34(6):585–612. doi: 10.1038/bjc.1976.220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Rees M., Leigh S. E., Delhanty J. D., Jass J. R. Chromosome 5 allele loss in familial and sporadic colorectal adenomas. Br J Cancer. 1989 Mar;59(3):361–365. doi: 10.1038/bjc.1989.72. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Rowley H., Jones A. S., Field J. K. Chromosome 18: a possible site for a tumour suppressor gene deletion in squamous cell carcinoma of the head and neck. Clin Otolaryngol Allied Sci. 1995 Jun;20(3):266–271. doi: 10.1111/j.1365-2273.1995.tb01864.x. [DOI] [PubMed] [Google Scholar]
  28. Sato T., Saito H., Morita R., Koi S., Lee J. H., Nakamura Y. Allelotype of human ovarian cancer. Cancer Res. 1991 Oct 1;51(19):5118–5122. [PubMed] [Google Scholar]
  29. Sato T., Tanigami A., Yamakawa K., Akiyama F., Kasumi F., Sakamoto G., Nakamura Y. Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res. 1990 Nov 15;50(22):7184–7189. [PubMed] [Google Scholar]
  30. Tsuchiya E., Nakamura Y., Weng S. Y., Nakagawa K., Tsuchiya S., Sugano H., Kitagawa T. Allelotype of non-small cell lung carcinoma--comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma. Cancer Res. 1992 May 1;52(9):2478–2481. [PubMed] [Google Scholar]
  31. Uzawa K., Yoshida H., Suzuki H., Tanzawa H., Shimazaki J., Seino S., Sato K. Abnormalities of the adenomatous polyposis coli gene in human oral squamous-cell carcinoma. Int J Cancer. 1994 Sep 15;58(6):814–817. doi: 10.1002/ijc.2910580611. [DOI] [PubMed] [Google Scholar]
  32. Vogelstein B., Fearon E. R., Kern S. E., Hamilton S. R., Preisinger A. C., Nakamura Y., White R. Allelotype of colorectal carcinomas. Science. 1989 Apr 14;244(4901):207–211. doi: 10.1126/science.2565047. [DOI] [PubMed] [Google Scholar]
  33. Yamaguchi T., Toguchida J., Yamamuro T., Kotoura Y., Takada N., Kawaguchi N., Kaneko Y., Nakamura Y., Sasaki M. S., Ishizaki K. Allelotype analysis in osteosarcomas: frequent allele loss on 3q, 13q, 17p, and 18q. Cancer Res. 1992 May 1;52(9):2419–2423. [PubMed] [Google Scholar]
  34. Yoo G. H., Xu H. J., Brennan J. A., Westra W., Hruban R. H., Koch W., Benedict W. F., Sidransky D. Infrequent inactivation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma. Cancer Res. 1994 Sep 1;54(17):4603–4606. [PubMed] [Google Scholar]
  35. van der Riet P., Nawroz H., Hruban R. H., Corio R., Tokino K., Koch W., Sidransky D. Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Res. 1994 Mar 1;54(5):1156–1158. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES